Legal & General Group PLC Unity Biotechnology, Inc. Transaction History

Legal & General Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$4.15 - $6.3 $16,139 - $24,500	-3,889 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.51 - $9.42 $1,305 - $2,232	-237 Reduced 5.74%	3,889 $23,000
Q3 2020 Nov 13, 2020	SELL	$2.94 - $12.43 $3,751 - $15,860	-1,276 Reduced 23.62%	4,126 $14,000
Q2 2020 Aug 14, 2020	BUY	$5.28 - $9.67 $4,319 - $7,910	818 Added 17.84%	5,402 $47,000
Q1 2020 May 14, 2020	SELL	$5.0 - $7.6 $5,105 - $7,759	-1,021 Reduced 18.22%	4,584 $27,000
Q4 2019 Feb 13, 2020	BUY	$5.99 - $8.38 $4,917 - $6,879	821 Added 17.16%	5,605 $40,000
Q2 2019 Aug 14, 2019	BUY	$7.59 - $10.21 $6,990 - $9,403	921 Added 23.84%	4,784 $40,000
Q4 2018 Feb 15, 2019	BUY	$10.76 - $17.25 $33,517 - $53,733	3,115 Added 416.44%	3,863 $63,000
Q2 2018 Aug 10, 2018	BUY	$12.76 - $16.94 $9,544 - $12,671	748 New	748 $11,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $30.2M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.